Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoserine aminotransferase 1 pseudogene 1 (PSAT1P1) is a human genetic locus whose sequence closely resembles that of the active PSAT1, which encodes an enzyme crucial for L-serine biosynthesis[3]. PSAT1P1, identified as a pseudogene on multiple chromosomes, does not produce a functional protein. Its biological relevance is typically limited to its value for evolutionary or genetic studies and it is not recognized as a target for drug development or diagnostic applications[3][5]. Additional context: - The functional protein, phosphoserine aminotransferase 1 (PSAT1), is an enzyme in the serine synthesis pathway, with significant roles in cell proliferation and tumor metabolism[1][2][5]. However, the pseudogene variant (PSAT1P1) lacks this enzymatic activity and is not a molecular target nor involved in these roles. - Pseudogenes can sometimes impact gene regulation, but there is no evidence in curated databases or the biomedical literature indicating PSAT1P1 is involved in regulating PSAT1 or any other gene, or in disease causation. - If the query intended PSAT1 (the enzyme) instead of PSAT1P1, please clarify, as PSAT1 has established roles in cancer and cellular metabolism and is actively investigated as a therapeutic target[1][2][5]. Summary of issues: - PSAT1P1 is not a therapeutic target. - It does not encode a protein, have biological function, or play a role in disease or drug interaction. - If searching for a valid therapeutic target, consider the functional gene "Phosphoserine aminotransferase 1 (PSAT1)," not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoserine aminotransferase 1 pseudogene 1 (PSAT1P1).